Abstract
Effective parenteral antibiotic regimens benefit patients with cutaneous, neurologic, cardiac, or joint features of Lyme disease. However, in patients whose only evidence for Lyme disease is a positive immunologic test result, the risks for empiric, intravenous antibiotic treatment outweigh the benefits.
Original language | English (US) |
---|---|
Pages (from-to) | 518 |
Number of pages | 1 |
Journal | Annals of internal medicine |
Volume | 119 |
Issue number | 6 |
DOIs | |
State | Published - 1993 |
ASJC Scopus subject areas
- Internal Medicine